[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100535670":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":24,"centralContacts":28,"locations":38,"responsibleParty":55,"collaborators":19,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":19,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":41,"whyStopped":19,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Primary screening for UCC","Women aged between 30 and 65 who are candidates for primary screening for UCC will be included.",[12,13],"Other: Urine sample, 1st stream","Other: Cervico-vaginal swab",[15,20],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Urine sample, 1st stream","Use of the Colli-Pee® device for collecting the first urine stream",[9],null,{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":19},"Cervico-vaginal swab","Use of a \"gold standard\" reference method = HPV PCR using the Anyplex® II HPV HR kit (Seegene) carried out on a cervico-vaginal swab in ThinPrep® medium (liquid medium medium into which the cervico-vaginal swab is discharged).",[9],[25],{"name":26,"affiliation":5,"role":27},"Louise MONIOD, MD","PRINCIPAL_INVESTIGATOR",[29,34],{"name":26,"role":30,"phone":31,"phoneExt":32,"email":33},"CONTACT","(0)4 77 82 83 83","+33","louise.moniod@chu-st-etienne.fr",{"name":35,"role":30,"phone":36,"phoneExt":32,"email":37},"Florence RANCON","(0)4 77 12 08 26","florence.rancon@chu-st-etienne.fr",[39],{"facility":40,"status":41,"city":42,"state":19,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Service de Gynécologie Obstétrique - CHU Saint-Etienne","RECRUITING","Saint-Etienne","42055","France","FR",{"type":47,"coordinates":48},"Point",[49,50],4.39,45.43389,{"lat":50,"lon":49},[53],{"name":54,"role":27,"phone":19,"phoneExt":19,"email":19},"Chauleur Céline, MD PhD",{"type":56,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100535670","evaluation-of-first-void-urine-as-an-alternative-to-cervical-sampling-for-human-papillomavirus-hpv-testing-in-cervical-cancer-screening-single-center-study-100535670",false,"NCT06254846","Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).","URAPREV","Inclusion Criteria:\n\n* Female\n* Age between 30 and 65\n* Consulting in the Gynecology-Obstetrics department for primary cervical cancer screening\n* Patient affiliated or entitled to a social security regimen\n* Patient who has received information about the study and expressed non-opposition\n\nExclusion Criteria:\n\n\\-",true,"FEMALE","30 Years","65 Years",{"count":69,"type":70},350,"ESTIMATED","INTERVENTIONAL",[73],"NA","Papillomaviruses are responsible for almost all cervical cancers. In France, there are more than 3000 new cases of cervical cancer each year and nearly 1000 deaths. One of the ways to prevent this cancer is screening by PCR on cervical sample for which national coverage rate remains very insufficient (\\\u003C60%). The invasive and uncomfortable nature of cervical sampling has been identified as a major obstacle to screening. In this context, an alternative sample, such as the first-void urine, seems to be judicious. Nevertheless, some studies have shown a lack of sensitivity of the HPV PCR test on urine. As underlined by the French National Authority for Health (HAS), this is mainly due to a lack of standardization of urine collection. In this study, the investigators therefore propose to evaluate the performance of the HPV PCR test on first-void urine using a standardized protocol. Through a questionnaire, they will also evaluate the acceptability of the first void urine collection device.",[76],"Uterine Cervical Cancer",[78,79,80],"HPV","Cervical cancer","Cancer screening","2026-05-05",{"date":83,"type":84},"2026-05-06","ACTUAL",{"date":86,"type":84},"2024-05-23",{"date":88,"type":70},"2027-05",{"name":5,"class":6},1]